Endovia Health Sciences (EDVA) Change in Cash (2012 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Change in Cash (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | -138,493.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -138,493.00 |
| Mar 31, 2026 | 99,760.00 |
| Dec 31, 2025 | 17,325.00 |
| Sep 30, 2025 | 248,454.00 |
| Jun 30, 2025 | 17,213.00 |
| Mar 31, 2025 | -15,346.00 |
| Dec 31, 2024 | -230,288.00 |
| Sep 30, 2024 | 448,589.00 |
| Jun 30, 2024 | -6,459.00 |
| Mar 31, 2024 | -365,221.00 |
| Dec 31, 2023 | 283,857.00 |
| Sep 30, 2023 | -807,114.00 |
| Jun 30, 2023 | -1.24 Mn |
| Mar 31, 2023 | -2.29 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Sep 30, 2022 | -1.60 Mn |
| Jun 30, 2022 | -4.29 Mn |
| Mar 31, 2022 | 4.31 Mn |
| Dec 31, 2021 | -3.96 Mn |
| Sep 30, 2021 | -3.80 Mn |